<html>
<head>PUBMED IDs for APOBEC-1</head>
<body bgcolor='#C5F0F2'><h1>APOBEC-1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8621694/'>Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing.</a> February 9  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8999814/'>Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.</a> January 17  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9344612/'>A complete epithelial organization of Caco-2 cells induces I-FABP and potentializes apolipoprotein gene expression.</a> November 5  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9479499/'>Human apolipoprotein B RNA editing deaminase gene (APOBEC1).</a> February 28  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9633945/'>Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.</a> June 20  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9672068/'>Distinct promoters induce APOBEC-1 expression in rat liver and intestine.</a> July 22  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9822632/'>Secondary structure for the apolipoprotein B mRNA editing site. Au-binding proteins interact with a stem loop.</a> November 21  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10064724/'>Transgenic rabbits as models for atherosclerosis research.</a> March 5  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10373583/'>C--&gt;U editing of apolipoprotein B mRNA in marsupials: identification and characterisation of APOBEC-1 from the American opossum Monodelphus domestica.</a> June 22  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10403781/'>APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family.</a> July 15  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11292850/'>Identification of the yeast cytidine deaminase CDD1 as an orphan C--&gt;U RNA editase.</a> April 9  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11809850/'>Apolipoprotein B mRNA editing and the reduction in synthesis and secretion of the atherogenic risk factor, apolipoprotein B100 can be effectively targeted through TAT-mediated protein transduction.</a> January 26  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/11815617/'>Two proteins essential for apolipoprotein B mRNA editing are expressed from a single gene through alternative splicing.</a> January 30  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/11870221/'>The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.</a> March 1  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12181361/'>Differential expression of NAT1 translational repressor during development of bovine intramuscular adipocytes.</a> August 16  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12359328/'>Reduced expression and increased CpG dinucleotide methylation of the rat APOBEC-1 promoter in transgenic rabbits.</a> October 3  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12374571/'>Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.</a> October 11  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12374501/'>Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families.</a> October 11  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12618436/'>Requirement of dimerization for RNA editing activity of adenosine deaminases acting on RNA.</a> March 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14991614/'>Non-redundancy of cytidine deaminases in class switch recombination.</a> March 3  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15451168/'>Gene structure and expression of the mouse APOBEC-1 complementation factor: multiple transcriptional initiation sites and a spliced variant with a premature stop translation codon.</a> September 29  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15668174/'>Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.</a> January 26  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16219354/'>The cytidine deaminase AID exhibits similar functional properties in yeast and mammals.</a> October 13  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16687409/'>Identification of a specific domain required for dimerization of activation-induced cytidine deaminase.</a> May 12  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/20348446/'>Hypermutation induced by APOBEC-1 overexpression can be eliminated.</a> May 7  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20541607/'>Metabolic regulation of APOBEC-1 complementation factor trafficking in mouse models of obesity and its positive correlation with the expression of ApoB protein in hepatocytes.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20836050/'>APOBEC-1-mediated RNA editing.</a> January 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22985273/'>Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia.</a> July 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22985268/'>Clinical isolates of Yersinia enterocolitica biotype 1A represent two phylogenetic lineages with differing pathogenicity-related properties.</a> May 15  2012<br></body></html>
